TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 1 filers reported holding TRAVERE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,579 | -33.5% | 288,654 | +14.3% | 0.00% | 0.0% |
| Q2 2023 | $3,879 | -15.0% | 252,583 | +24.6% | 0.00% | 0.0% |
| Q1 2023 | $4,561 | +17.4% | 202,786 | +9.7% | 0.00% | 0.0% |
| Q4 2022 | $3,885 | -99.9% | 184,786 | +35.0% | 0.00% | -50.0% |
| Q3 2022 | $3,374,000 | +445.1% | 136,913 | +435.7% | 0.00% | – |
| Q2 2022 | $619,000 | -50.9% | 25,556 | -47.7% | 0.00% | -100.0% |
| Q1 2022 | $1,261,000 | – | 48,901 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MASSMUTUAL TRUST CO FSB/ADV | 235 | $2,113 | 0.00% |